Clinical Trial Update: Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating ONL1204 for geographic atrophy associated with age-related macular degeneration is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• ONL1204

Snippet

Sponsor: ONL Therapeutics | Conditions: Geographic Atrophy (GA), Age - Related Macular Degeneration (AMD) | Phase 2 | Status: RECRUITING